Abstract
Genome-wide DNA methylomes have contributed greatly to tumor detection and subclassification. However, interpreting the biological impact of the DNA methylome at the individual gene level remains a challenge. MethylationToActivity (M2A) is a pipeline that uses convolutional neural networks to infer H3K4me3 and H3K27ac enrichment from DNA methylomes and thus infer promoter activity. It was shown to be highly accurate and robust in revealing promoter activity landscapes in various pediatric and adult cancers. The following will present a user-friendly guide through the model pipeline.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH (2008) The functional consequences of alternative promoter use in mammalian genomes. Trends Genet 24:167–177. https://doi.org/10.1016/j.tig.2008.01.008
Demircioglu D et al (2019) A pan-cancer transcriptome analysis reveals pervasive regulation through alternative promoters. Cell 178:1465–1477 e1417. https://doi.org/10.1016/j.cell.2019.08.018
Qamra A et al (2017) Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma. Cancer Discov 7:630–651. https://doi.org/10.1158/2159-8290.CD-16-1022
Sotillo E et al (2015) Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov 5:1282–1295. https://doi.org/10.1158/2159-8290.CD-15-1020
Grobner SN et al (2018) The landscape of genomic alterations across childhood cancers. Nature 555:321–327. https://doi.org/10.1038/nature25480
Ma X et al (2018) Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature 555:371–376. https://doi.org/10.1038/nature25795
Huether R et al (2014) The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun 5:3630. https://doi.org/10.1038/ncomms4630
Dong X et al (2012) Modeling gene expression using chromatin features in various cellular contexts. Genome Biol 13:R53. https://doi.org/10.1186/gb-2012-13-9-r53
Karlic R, Chung HR, Lasserre J, Vlahovicek K, Vingron M (2010) Histone modification levels are predictive for gene expression. Proc Natl Acad Sci U S A 107:2926–2931. https://doi.org/10.1073/pnas.0909344107
Singh R, Lanchantin J, Robins G, Qi Y (2016) DeepChrome: deep-learning for predicting gene expression from histone modifications. Bioinformatics 32:i639–i648. https://doi.org/10.1093/bioinformatics/btw427
Kelley DZ et al (2017) Integrated analysis of whole-genome ChIP-Seq and RNA-Seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks. Cancer Res 77:6538–6550. https://doi.org/10.1158/0008-5472.CAN-17-0833
Skene PJ, Henikoff S (2017) An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife 6. https://doi.org/10.7554/eLife.21856
Kagohara LT et al (2018) Epigenetic regulation of gene expression in cancer: techniques, resources and analysis. Brief Funct Genomics 17:49–63. https://doi.org/10.1093/bfgp/elx018
Zhang P, Lehmann BD, Shyr Y, Guo Y (2017) The utilization of formalin fixed-paraffin-embedded specimens in high throughput genomic studies. Int J Genomics 2017:1926304. https://doi.org/10.1155/2017/1926304
de Ruijter TC et al (2015) Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays. Lab Invest 95:833–842. https://doi.org/10.1038/labinvest.2015.53
Moran S et al (2014) Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 Microarray. Epigenetics 9:829–833. https://doi.org/10.4161/epi.28790
Gu H et al (2010) Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 7:133–136. https://doi.org/10.1038/nmeth.1414
Charlet J et al (2016) Bivalent regions of cytosine methylation and H3K27 acetylation suggest an active role for DNA methylation at enhancers. Mol Cell 62:422–431. https://doi.org/10.1016/j.molcel.2016.03.033
Kondo Y (2009) Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med J 50:455–463. https://doi.org/10.3349/ymj.2009.50.4.455
Onuchic V et al (2018) Allele-specific epigenome maps reveal sequence-dependent stochastic switching at regulatory loci. Science 361. https://doi.org/10.1126/science.aar3146
Rothbart SB, Strahl BD (1839) Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 627-643:2014. https://doi.org/10.1016/j.bbagrm.2014.03.001
Sheffield NC et al (2017) DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. Nat Med 23:386–395. https://doi.org/10.1038/nm.4273
Stadler MB et al (2011) DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480:490–495. https://doi.org/10.1038/nature10716
Zhu H, Wang G, Qian J (2016) Transcription factors as readers and effectors of DNA methylation. Nat Rev Genet 17:551–565. https://doi.org/10.1038/nrg.2016.83
Ziller MJ et al (2013) Charting a dynamic DNA methylation landscape of the human genome. Nature 500:477–481. https://doi.org/10.1038/nature12433
Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H (2003) The role of DNA methylation in setting up chromatin structure during development. Nat Genet 34:187–192. https://doi.org/10.1038/ng1158
Moore LD, Le T, Fan G (2013) DNA methylation and its basic function. Neuropsychopharmacology 38:23–38. https://doi.org/10.1038/npp.2012.112
Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484–492. https://doi.org/10.1038/nrg3230
Lay FD et al (2015) The role of DNA methylation in directing the functional organization of the cancer epigenome. Genome Res 25:467–477. https://doi.org/10.1101/gr.183368.114
Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2(Suppl 1):S4–S11. https://doi.org/10.1038/ncponc0354
Williams J et al (2021) MethylationToActivity: a deep-learning framework that reveals promoter activity landscapes from DNA methylomes in individual tumors. Genome Biol 22:24. https://doi.org/10.1186/s13059-020-02220-y
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Dieseldorff Jones, K., Putnam, D., Williams, J., Chen, X. (2023). A Guide to MethylationToActivity: A Deep Learning Framework That Reveals Promoter Activity Landscapes from DNA Methylomes in Individual Tumors. In: Oliveira, P.H. (eds) Computational Epigenomics and Epitranscriptomics. Methods in Molecular Biology, vol 2624. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2962-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2962-8_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2961-1
Online ISBN: 978-1-0716-2962-8
eBook Packages: Springer Protocols